Anti-Jo-1 Antibodies
- 1 February 2005
- journal article
- review article
- Published by Taylor & Francis in Autoimmunity
- Vol. 38 (1) , 73-78
- https://doi.org/10.1080/08916930400022640
Abstract
Anti-Jo-1 antibody is a myositis specific autoantibody most commonly found in patients with idiopathic inflammatory myopathies (IIM). This antibody is directed against the histidyl-tRNA synthetase which catalyses the binding of the histidine to its cognate tRNA during protein synthesis. It can be considered a specific marker of IIM, predominantly found in 20-30% of patients with PM and in the 60-70% of those with interstitial pulmonary fibrosis. These antibodies are also found in DM, although less frequently than in PM, and are rare in children with PM or DM and in other connective tissue diseases.ELISA, CIE and immunoblotting are highly specific and sensitive techniques for testing anti-Jo-1 antibodies. The detection of this antibody is particularly useful in diagnosis and classification of IIM. Moreover, anti-Jo-1 serum levels strongly correlate with disease activity representing a good marker for disease monitoring.Keywords
This publication has 19 references indexed in Scilit:
- A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity and contains the major autoantigenic epitope.Published by Elsevier ,2021
- Frequent occurrence of anti-tRNAHis autoantibodies that recognize a conformational epitope in sera of patients with myositisArthritis & Rheumatism, 1998
- Antibodies to glycyl–transfer rna synthetase in patients with myositis and interstitial lung diseaseArthritis & Rheumatism, 1992
- The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity.Proceedings of the National Academy of Sciences, 1990
- Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase)The American Journal of Medicine, 1990
- Histidyl-tRNA synthetase, the myositis Jo-1 antigen, is cytoplasmic and unassociated with the cytoskeletal frameworkExperimental Cell Research, 1986
- Polymyositis and interstitial lung disease in a patient with anti-Jo1 prototypeThe American Journal of Medicine, 1984
- Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunityNature, 1983
- Heterogeneity of precipitating antibodies in polymyositis and dermatomyositisArthritis & Rheumatism, 1980
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975